Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-6 Guided Antibiotic Therapy in AECOPD
NCT06612476Not yet recruiting
- Sponsor
- First Affiliated Hospital of Ningbo University
- Start
- Sep 2024
- Primary completion
- Aug 2026
01
Overview
Randomised, open-label trial in chronic obstructive pulmonary disease (COPD), sponsored by First Affiliated Hospital of Ningbo University. Primary endpoints: Incidence of antibiotic use at 30 days and Proportion of successful treatments at 30 days. Planned start Sep 2024; status: not yet recruiting.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06612476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06612476.